首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
CRYSTAL FORMS OF O-DESMETHYLVENLAFAXINE FUMARATE
摘要
<p>Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof.</p>
申请公布号
WO2009070311(A3)
申请公布日期
2009.11.12
申请号
WO2008US13170
申请日期
2008.11.26
申请人
TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;NIDDAM-HILDESHEIM, VALERIE;LANCRY, ELI;SHACHAN-TOV, SHARONA;LEVI, SIGALIT;NIDAM, TAMAR
发明人
NIDDAM-HILDESHEIM, VALERIE;LANCRY, ELI;SHACHAN-TOV, SHARONA;LEVI, SIGALIT;NIDAM, TAMAR
分类号
C07C215/64;A61K31/137;A61P25/24;C07C57/15;C07C213/10
主分类号
C07C215/64
代理机构
代理人
主权项
地址
您可能感兴趣的专利
SYSTEM AND METHOD FOR DETERMINING THE ROUTE AND/OR VELOCITY OF VEHICLES, IN PARTICULAR IN ORDER TO CONTROL TRAINS
REDUCING THE COST OF DISTRIBUTED ELECTRICITY GENERATION THROUGH OPPORTUNITY GENERATION
ANTAGONIZING AN ADENOSINE A2A RECEPTOR TO AMELIORIATE ONE OR MORE COMPONENTS OF ADDICTIVE BEHAVIOR
PYRROLOTRIAZINE KINASE INHIBITORS
METHOD AND APPARATUS FOR LAUNCHING A SURFACEWAVE ONTO A SINGLE CONDUCTOR TRANSMISSION LINE
METHODS AND COMPOSITIONS FOR THE TREATMENT OF ISCHEMIC REPERFUSION
HOT-MELT EXTRUDABLE PHARMACEUTICAL FORMULATION
ALPHA-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS
METHOD AND APPARATUS FOR IMPROVED PROCESSING WITH A GAS-CLUSTER ION BEAM
DISPOSITIVO PER IL SOLLEVAMENTO ED IL TRASFERIMENTO DI PERSONE AVENTI LIMITAZIONI FUNZIONALI DEGLI ARTI INFERIORI
SYSTEM FOR MANAGING INFORMATION DISPLAY BY SUPPORTS AS A FUNCTION OF THE DISTRIBUTION OF THE PROFILES OF TARGET PERSONS PRESENTED IN THEIR VICINITY
METHOD FOR OPERATING AN INTERNAL COMBUSTION ENGINE
EXERCISE MANAGEMENT SYSTEM, EXERCISE MANAGEMENT METHOD, AND EXERCISE MANAGEMENT PROGRAM
SISTEMA DI GESTIONE ELETTRONICA DELLE AREE DI SOSTA PUBBLICHE A PAGAMENTO
X-RAY IMAGE TUBE, X-RAY IMAGE TUBE DEVICE AND X-RAY DEVICE
HUMAN SECRETED PROTEINS
CLAMP FOR JOINING TUBULAR BODIES
FUNGAL MATERIAL STABILISATION
AGENT FOR PREVENTING AND AMELIORATING CONSTIPATION
TARGET NUCLEIC ACID OF RETROVIRUS INTEGRATION